1. Home
  2. STRL vs CRSP Comparison

STRL vs CRSP Comparison

Compare STRL & CRSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STRL
  • CRSP
  • Stock Information
  • Founded
  • STRL 1955
  • CRSP 2013
  • Country
  • STRL United States
  • CRSP Switzerland
  • Employees
  • STRL N/A
  • CRSP N/A
  • Industry
  • STRL Military/Government/Technical
  • CRSP Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • STRL Industrials
  • CRSP Health Care
  • Exchange
  • STRL Nasdaq
  • CRSP Nasdaq
  • Market Cap
  • STRL 4.1B
  • CRSP 3.4B
  • IPO Year
  • STRL N/A
  • CRSP 2016
  • Fundamental
  • Price
  • STRL $116.29
  • CRSP $47.87
  • Analyst Decision
  • STRL Buy
  • CRSP Buy
  • Analyst Count
  • STRL 2
  • CRSP 21
  • Target Price
  • STRL $115.00
  • CRSP $75.42
  • AVG Volume (30 Days)
  • STRL 635.5K
  • CRSP 2.7M
  • Earning Date
  • STRL 02-25-2025
  • CRSP 02-11-2025
  • Dividend Yield
  • STRL N/A
  • CRSP N/A
  • EPS Growth
  • STRL 40.91
  • CRSP N/A
  • EPS
  • STRL 5.89
  • CRSP N/A
  • Revenue
  • STRL $2,102,900,999.00
  • CRSP $37,314,000.00
  • Revenue This Year
  • STRL $11.09
  • CRSP $227.76
  • Revenue Next Year
  • STRL $1.55
  • CRSP $353.05
  • P/E Ratio
  • STRL $19.73
  • CRSP N/A
  • Revenue Growth
  • STRL 8.69
  • CRSP N/A
  • 52 Week Low
  • STRL $84.41
  • CRSP $36.52
  • 52 Week High
  • STRL $206.07
  • CRSP $90.62
  • Technical
  • Relative Strength Index (RSI)
  • STRL 27.30
  • CRSP 58.27
  • Support Level
  • STRL $127.50
  • CRSP $38.28
  • Resistance Level
  • STRL $135.94
  • CRSP $55.88
  • Average True Range (ATR)
  • STRL 7.19
  • CRSP 2.87
  • MACD
  • STRL -1.84
  • CRSP 1.07
  • Stochastic Oscillator
  • STRL 0.30
  • CRSP 54.50

About STRL Sterling Infrastructure Inc.

Sterling Infrastructure Inc is a construction company that specializes in heavy civil infrastructure construction and infrastructure rehabilitation as well as residential construction projects. The company operates in three reportable segments namely, Transportation Solutions, E-Infrastructure Solutions, and Building Solution. Transportation Solutions include highways, roads, bridges, airfields, ports, light rail, and others. Building Solution projects include concrete foundations for single-family homes. E-Infrastructure Solutions include the services which are provided to large, blue-chip companies in the e-commerce, data center, distribution center, and warehousing, energy, mixed-use, and multi-family sectors. The majority of the revenue is generated from E-Infrastructure Solutions. .

About CRSP CRISPR Therapeutics AG

Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. Crispr's first approved drug is Casgevy, which was developed in collaboration with Vertex Pharmaceuticals and targets sickle-cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is advancing a variety of gene editing programs in immuno-oncology, cardiovascular, and a stem cell-derived therapy to treat Type 1 diabetes.

Share on Social Networks: